Safety Study of Human Recombinant Tissue Non-Specific Alkaline Phosphatase Fusion Protein Asfotase Alfa in Adults With Hypophosphatasia (HPP)
Clinical trial NCT00739505 · COMPLETED
Trial details
- NCT number
- NCT00739505
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-08-01
- Primary completion
- 2009-01-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.